Table 2.
Treatment process variables and serious adverse events (SAEs) by treatment assignment
| Variable | CBT4CBT N=47 |
TAU N=54 |
F | p | ||
|---|---|---|---|---|---|---|
|
| ||||||
| N or Mean | Sd or % | N or mean | Sd or % | |||
| Days In treatment (maximum =56) | 46.7 | 17.2 | 43.9 | 19.9 | 0.58 | .45 |
| Urine specimens provided | 9.5 | 5.0 | 10.8 | 2.8 | 1.81 | .18 |
| Total individual sessions within treatment | 3.7 | 1.8 | 4.2 | 2.8 | 0.8 | .38 |
| Total group sessions within treatment | 6.3 | 8.6 | 5.2 | 7.3 | 0.3 | .56 |
| Number (%) of participants with 1 or more SAEs1 within treatment | 3 | 6.4 | 1 | 1.9 | 1.4 | .24 |
| Number (%) of participants with 1 or more SAEs during follow-up | 8 | 17 | 6 | 11.1 | 0.8 | .39 |
Note. SAEs included medical hospitalizations (asthma, heart conditions) or brief inpatient substance use detoxification or stabilization.